Search results for "NOAC"

showing 10 items of 144 documents

Ionic liquids as solvents for the Knoevenagel condensation: understanding the role of solvent–solute interactions

2015

The Knoevenagel condensation in ionic liquids has been demonstrated as a strongly solvent-dependent process. The objective of this study was to establish a simple and descriptive trend of solvent–solute interactions that favour the Knoevenagel condensation in ionic liquid media. The reaction between 4-(dimethylamino)benzaldehyde and ethyl cyanoacetate in several imidazolium- and pyrrolidinium-based ionic liquids and one ionic liquid mixture was studied. The rate constants were rationalised by studying the change in the 1H NMR chemical shift of representative starting materials in the ionic liquids and the measurement and consideration of the Kamlet–Taft descriptors for each solvent. The hyd…

Hydrogen bondChemistryGeneral ChemistryCatalysisSolventBenzaldehydechemistry.chemical_compoundReaction rate constantEthyl cyanoacetateIonic liquidMaterials ChemistryProton NMROrganic chemistryKnoevenagel condensationNew Journal of Chemistry
researchProduct

Presence and coding properties of 2'-O-methyl-5-carbamoylmethyluridine (ncm5Um) in the wobble position of the anticodon of tRNA(Leu) (U*AA) from brew…

1992

AbstractThe unknown modified nucleoside U* has been isolated by enzymatic and HPLC protocols from tRNALeu(U*AA) recently discovered in brewer's yeast. The pure U* nucleoside has been characterized by electron impact mass spectroscopy, and comparison of its chromatographic and UV-absorption properties with those of appropriate synthetic compounds. The structure of U* was established as 2′-O-methyl-5-carbamoylmethyluridine (ncm5Um). The yeast tRNALeu (U*AA) is the only tRNA so far sequenced which has been shown to contain ncm5Um. The location of such a modified uridine at the first position of the anticodon restricts the decoding property to A of the leucine UUA codon.

IdentificationRNA Transfer LeuStereochemistryBiophysicsAminoacylationWobble base pairModified nucleosideSaccharomyces cerevisiaeBiochemistryMass SpectrometryFungal Proteinschemistry.chemical_compoundStructural BiologyGeneticsAnticodonMolecular BiologyUridineChromatography High Pressure Liquidchemistry.chemical_classificationMolecular StructureRNA FungalCell BiologyUridineYeastYeastEnzymechemistryBiochemistryTransfer RNAtRNALeu (U*AA)Spectrophotometry UltravioletLeucineNucleosideFEBS letters
researchProduct

1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase A

2020

The inhibition or prevention of biofilm formation represents an emerging strategy in the war against antibiotic resistance, interfering with key players in bacterial virulence. This approach includes the inhibition of the catalytic activity of transpeptidase sortase A (Srt A), a membrane enzyme responsible for covalently attaching a wide variety of adhesive matrix molecules to the peptidoglycan cell wall in Gram-positive strains. A new series of seventeen 1,2,4-oxadiazole derivatives was efficiently synthesized and screened as potential new anti-virulence agents. The ability of inhibiting biofilm formation was evaluated against both Gram-positive and Gram-negative pathogens. Remarkably, all…

Indoles124-Oxadiazoles Antibiofilm activity Sortase A inhibitors Anti-virulence agents Marine alkaloids Topsentin analogs01 natural scienceslaw.inventionchemistry.chemical_compoundMarine alkaloidslawDrug DiscoveryPathogenchemistry.chemical_classificationOxadiazoles0303 health sciencesChemistry4-OxadiazolesImidazolesGeneral MedicineStaphylococcal InfectionsAminoacyltransferasesAnti-Bacterial AgentsCysteine EndopeptidasesAnti-virulence agentsBiochemistrySortase AAntibiofilm activityPseudomonas aeruginosaTopsentin analogsRecombinant DNA124-Oxadiazoles; Anti-virulence agents; Antibiofilm activity; Marine alkaloids; Sortase A inhibitors; Topsentin analogsStaphylococcus aureus12Sortase A inhibitorsCell LineCell wall03 medical and health sciencesAntibiotic resistanceBacterial Proteins124-OxadiazolesHumansPseudomonas Infections030304 developmental biologyPharmacology010405 organic chemistryOrganic ChemistryBiofilmSettore CHIM/08 - Chimica Farmaceutica0104 chemical sciencesEnzymeBiofilmsPeptidoglycan
researchProduct

Reacciones de cicloadición formal enantioselectivas con isocianoacetatos

2020

En la presente tesis doctoral se ha llevado a cabo el estudio de la cicloadición formal [3+2] enantioselectiva de isocianoacetatos a diferentes electrófilos para la formación de nuevas estructuras cíclicas nitrogenadas. Para ello, se ha desarrollado un método catalítico cooperativo consistente en un organocatalizador bifuncional de tipo escuaramida y óxido de plata como ácido de Lewis. En el primer capítulo se ha estudiado la reacción de adición de isocianoacetatos a trifluoroacetofenonas para la obtención de 2-oxazolinas con dos centros estereogénicos consecutivos, siendo uno de ellos cuaternario y estando sustituido con un grupo trifluorometilo. Se ha estudiado el alcance y las limitacion…

IsocianoacetatosUNESCO::QUÍMICAcatálisissíntesis orgánica:QUÍMICA [UNESCO]
researchProduct

Benzaldehīda kondensācijas reakcijas ar etilciānoacetātu un malonskābi jonu šķidrumos

2015

Benzaldehīda kondensācijas reakcijas ar etilciānoacetātu un malonskābi jonu šķidrumos. Kolesnikova K., zinātniskais vadītājs Dr.h.ķīm., prof. Zicmanis A. Maģistra darbs, 79 lappuses, 53 attēli, 24 tabulas, 69 literatūras avoti. Latviešu valodā. Maģistra darbā ir apkopota vispārīga informācija par jonu šķidrumiem: iegūšanas metodēm, to īpašībām un izmantošanas iespējām, kā arī aplūkota literatūra par Knēvenāgela kondensāciju un tās Dēbnera modifikāciju. Darbā ir veikta vairāku jonu šķidrumu sintēze. Iegūto jonu šķidrumu struktūras tika pieradītas ar 1H KMR spektroskopijas metodi, tad JŠ tika izmantoti kā šķīdinātāji Knēvenāgela kondensācijas reakcijā un Knēvenāgela-Dēbnera kondensācijas reak…

JONU ŠĶIDRUMIMALONSKĀBEBENZALDEHĪDSETILCIĀNOACETĀTSETIL-2-CIĀNO-3-FENILPROPENOĀTSĶīmija
researchProduct

Dažu karbonilsavienojumu kondensācija ar etilcianoacetātu jonu šķidrumu vidēs

2017

Dažu karbonilsavienojumu kondensācija ar etilcianoacetātu jonu šķidrumu vidēs. Kuļikovska L., darba vadītājs Dr.h.ķīm., prof. Zicmanis A. Bakalaura darbs, 55 lappuses, 20 attēli, 6 tabulas, 52 literatūras avoti, 18 pielikums. Latviešu valodā. Literatūras apskata daļa satur vispārīgu informāciju par jonu šķidrumu iegūšanu, to uzbūvi, īpašībām, attīrīšanu, kā arī literatūras apskatu par jonu šķidrumu izmantošanu Knēvenāgela kondensācijas reakcijās. Laboratorijā tika iegūti vairāki 1,3-dialkilimidazolija un 1,2,3-tiralkilimidazolija rindas jonu šķidrumu ar hlorīda un dimetilfosfāta anjoniem, izmantojot dažādas metodes. Iegūto savienojumu struktūras raksturotas ar 1H KMR metodi un noteiktas to …

KNĒVENĀGELA KONDENSĀCIJAKINĒTIKAJONU ŠĶIDRUMIETILCIANOACETĀTSĶīmija
researchProduct

2,4-Dimetoksibenzaldehīda kondensācija ar etilcianoacetātu jonu šķidrumu vidēs

2019

2,4-Dimetoksibenzaldehīda kondensācija ar etilcianoacetātu jonu šķidrumu vidēs. Maševska Z., zinātniskais vadītājs prof., Dr.h.ķīm. Zicmanis A. Maģistra darbs, 54 lappuses, 14 attēli, 10 tabulas, 66 literatūras avoti, 19 pielikumi. Latviešu valodā. Darbā apkopota literatūra par jonu šķidrumu iegūšanas metodēm, to attīrīšanu, toksiskajām īpašībām, fizikāli-ķīmiskajām īpašībām. Apkopota informācija par Knēvenāgela kondensācijas reakcijas principiem. Sintezēti 17 strukturāli atšķirīgi jonu šķidrumi. Veiktas Knēvenāgela kondensācijas reakcijas jonu šķidrumu vidēs, izvērtēti iegūtie rezultāti. Iegūtie rezultāti salīdzināti ar citiem līdzīgiem pētījumiem.

KNĒVENĀGELA KONDENSĀCIJAS REAKCIJASETILCIANOACETĀTSBĀZISKIE JONU ŠĶIDRUMI24-DIMETOKSIBENZALDEHĪDSĶīmija
researchProduct

Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE-/- mice.

2018

Background The endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG) is a known modulator of inflammation and ligand to both, pro-inflammatory cannabinoid receptor 1 (CB1) and anti-inflammatory CB2. While the role of both receptors in atherogenesis has been studied extensively, the significance of 2-AG for atherogenesis is less well characterized. Methods The impact of 2-AG on atherogenesis was studied in two treatment groups of ApoE-/- mice. One group received the monoacylglycerol lipase (MAGL)-inhibitor JZL184 [5 mg/kg i.p.], which impairs 2-AG degradation and thus causes elevated 2-AG levels, the other group received vehicle for four weeks. Simultaneously, both groups were fed a high-chole…

Male0301 basic medicineCCR1Chemokinelcsh:MedicineSmooth Muscle Cells030204 cardiovascular system & hematologyPathology and Laboratory MedicineBiochemistryMonocytesWhite Blood CellsMicechemistry.chemical_compoundChemokine receptorSpectrum Analysis Techniques0302 clinical medicinePiperidinesAnimal CellsCell MovementMedicine and Health SciencesReceptorlcsh:ScienceImmune ResponseJZL184MultidisciplinarybiologyNeurochemistryFlow CytometryLipidsCholesterolSpectrophotometryCytophotometryCellular TypesNeurochemicalsAnatomymedicine.symptomResearch Articlemedicine.medical_specialtyImmune CellsImmunologyMuscle TissueAntigens Differentiation MyelomonocyticInflammationArachidonic AcidsResearch and Analysis MethodsDiet High-FatCell LineGlycerides03 medical and health sciencesSigns and SymptomsApolipoproteins EDiagnostic MedicineAntigens CDInternal medicinemedicineAnimalsOil Red OBenzodioxolesInflammationMuscle CellsBlood CellsMacrophageslcsh:RBiology and Life SciencesCell BiologyAtherosclerosisMonoacylglycerol lipaseBiological Tissue030104 developmental biologyEndocrinologychemistrybiology.proteinlcsh:QEndocannabinoidsNeurosciencePLoS ONE
researchProduct

An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptake

2017

Targeted delivery of drugs across endothelial barriers remains a formidable challenge, especially in the case of the brain, where the blood-brain barrier severely limits entry of drugs into the central nervous system. Nanoparticle-mediated transport of peptide/protein-based drugs across endothelial barriers shows great potential as a therapeutic strategy in a wide variety of diseases. Functionalizing nanoparticles with peptides allows for more efficient targeting to specific organs. We have evaluated the hemocompatibilty, cytotoxicity, endothelial uptake, efficacy of delivery and safety of liposome, hyperbranched polyester, poly(glycidol) and acrylamide-based nanoparticles functionalized wi…

Male0301 basic medicinePharmaceutical ScienceMedicine (miscellaneous)LIPOSOMES02 engineering and technologyPharmacologyDrug Delivery SystemsTissue DistributionGeneral Materials ScienceDENDRIMERSDRUG-DELIVERYCytotoxicityDrug CarriersLiposomeBrain021001 nanoscience & nanotechnologyMETHOTREXATEmedicine.anatomical_structureBlood-Brain BarrierDrug deliveryMolecular MedicineNanomedicine0210 nano-technologyMaterials scienceBiomedical EngineeringBioengineeringBlood–brain barrierMEDIATED TRANSPORTCell Line03 medical and health sciencesIn vivomedicineAnimalsHumansAmino Acid SequenceRats WistarDENDRITIC POLYMERSTargetingSENSITIVE HYDROGELSBiological TransportIn vitron/a OA procedure030104 developmental biologyNANOGELSNanoparticles for drug delivery to the brain80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLESCELLSNanoparticlesPeptides
researchProduct

Influence of leucine on intestinal baclofen absorption as a model compound of neutral α-aminoacids

1995

The inhibitory effect of the essential alpha-aminoacid L-leucine on the intestinal absorption of the antispastic drug baclofen was examined by means of an in situ rat gut perfusion technique. When 0.5 mM baclofen solutions were perfused in the presence of increasing concentrations of the aminoacid (5-100 mM), the apparent absorption rate constant of the drug decreased as the initial leucine concentration increased. Higher leucine concentrations however did not completely abolish the absorption of the drug (at 100 mM of leucine, only 76% inhibition was observed). The interaction can be mathematically described as a complete competitive inhibition with a second component, K = 0.35 (+/- 0.08)h…

MaleAbsorption (pharmacology)Baclofenmedicine.medical_specialtyTime FactorsPharmaceutical ScienceModels BiologicalIntestinal absorptionchemistry.chemical_compoundNon-competitive inhibitionLeucineInternal medicinemedicineAnimalsPharmacology (medical)Amino AcidsRats WistarPharmacologychemistry.chemical_classificationChromatographyDose-Response Relationship DrugChemistryGeneral MedicineRatsAmino acidBioavailabilityDietary aminoacidKineticsBaclofenEndocrinologyIntestinal AbsorptionLeucineBiopharmaceutics & Drug Disposition
researchProduct